Financials data is unavailable for this security.
View more
Year on year Biodesix Inc grew revenues 28.46% from 38.21m to 49.09m while net income improved from a loss of 65.45m to a smaller loss of 52.15m.
| Gross margin | 77.72% |
|---|---|
| Net profit margin | -66.84% |
| Operating margin | -53.33% |
| Return on assets | -46.24% |
|---|---|
| Return on equity | -331.82% |
| Return on investment | -60.89% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Biodesix Inc fell by 16.80m. Cash Flow from Financing totalled 29.13m or 59.34% of revenues. In addition the company used 22.87m for operations while cash used for investing totalled 23.06m.
| Cash flow per share | -0.3334 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 0.1915 |
|---|---|
| Tangible book value per share | 0.0439 |
More ▼
Balance sheet in USDView more
| Current ratio | 3.40 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | 1.30 |
|---|---|
| Total debt/total capital | 0.5647 |
More ▼
